This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Martin Gilar, PhD
Scientific Fellow, Separations R&D at Waters Corporation


Dr. Martin Gilar (*1966) received his Ph.D. in analytical chemistry from Institute of Chemical Technology in Prague (1996). He spent postdoc years in Hybridon Inc. (1996-1998) and Northeastern University in Boston (1998) developing separation methods for antisense oligonucleotides and fraction collector for DNA molecules. Since 1998 he has worked at Waters Corp. in Milford, Massachusetts, participating in column, sample preparation and instrument research.

Dr. Martin Gilar is a Scientific Fellow in the Separations R&D group at Waters Corporation. He has more than 30 years of experience in the separation sciences, including chromatography, electrophoresis, and mass spectrometry. His research interest is the analysis of biopolymers, peptides, and nucleic acids. He has published over 75 peer reviewed papers. He is a recipient of Chromatographic Society Jubilee medal in 2022 and Jaroslav Janak 2022 medal from Academy of Science, Czech Republic.

Agenda Sessions

  • Oligonucleotide Analytics Overview with a Focus on Guide RNAs for CRISPR Applications

  • LC MS Methods for Characterization of Long Oligonucleotides